Peptide profile
CJC-1295
Also known as CJC-1295 with DAC
Long-acting growth hormone-releasing hormone analogue
Clinical research
Science, with its context intact.What to knowThe evidence
The evidence
in perspective.
A small study measured growth hormone and IGF-1 responses in healthy adults. Biomarker changes do not establish clinical benefit. This source concerns the long-acting DAC-linked compound.
View the supporting source- Research area
- Endocrine
- Biological target or mechanism
- Long-acting growth hormone-releasing hormone analogue
- Evidence context
- Clinical research
- Availability
- Availability requires pharmacy review
From information to a conversationClinical decisions stay
Clinical decisions stay
with clinical professionals.
This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.
